Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "amycretin"

2 News Found

Novo Nordisk to advance subcutaneous and oral amycretin for weight management into phase 3 clinical development
News | June 16, 2025

Novo Nordisk to advance subcutaneous and oral amycretin for weight management into phase 3 clinical development

The decision to advance subcutaneous and oral amycretin into phase 3 is based on feedback received from regulatory authorities


Novo Nordisk’s new diabetes combo drug delivers big wins in mid-stage trial
Clinical Trials | November 26, 2025

Novo Nordisk’s new diabetes combo drug delivers big wins in mid-stage trial

The trial tested six injectable doses and three oral doses over as long as 36 weeks